These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 2711157

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Treatment of Paget's disease of bone with single dose intravenous pamidronate.
    Watts RA, Skingle SJ, Bhambhani MM, Pountain G, Crisp AJ.
    Ann Rheum Dis; 1993 Aug; 52(8):616-8. PubMed ID: 8215628
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Effective oral treatment of severe Paget's disease of bone with APD (3-amino-1-hydroxypropylidene-1,1-bisphosphonate); a comparison with combined calcitonin + EHDP (1-hydroxyethylidene-1,1-bisphosphonate).
    Fraser TR, Ibbertson HK, Holdaway IM, Rutland M, King A, Dodd G, Wattie DJ.
    Aust N Z J Med; 1984 Dec; 14(6):811-8. PubMed ID: 6442563
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Intravenous aminopropylidene bisphosphonate (APD) in the treatment of Paget's bone disease.
    Vega E, Gonzalez D, Ghiringhelli G, Mautalen C.
    J Bone Miner Res; 1987 Aug; 2(4):267-71. PubMed ID: 3455613
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone.
    Adami S, Zamberlan N, Mian M, Dorizzi R, Rossini M, Braga B, Gatti D, Bertoldo F, Locascio V.
    Bone Miner; 1994 May; 25(2):75-82. PubMed ID: 8086853
    [Abstract] [Full Text] [Related]

  • 30. Paget's disease of bone: five regimens of pamidronate treatment.
    Pepersack T, Karmali R, Gillet C, François D, Fuss M.
    Clin Rheumatol; 1994 Mar; 13(1):39-44. PubMed ID: 8187442
    [Abstract] [Full Text] [Related]

  • 31. High-dose pamidronate in the management of resistant Paget's disease.
    Cundy T, Wattie D, King AR.
    Calcif Tissue Int; 1996 Jan; 58(1):6-8. PubMed ID: 8825232
    [Abstract] [Full Text] [Related]

  • 32. Bone scintigraphy following intravenous pamidronate for Paget's disease of bone.
    Ryan PJ, Gibson T, Fogelman I.
    J Nucl Med; 1992 Sep; 33(9):1589-93. PubMed ID: 1517830
    [Abstract] [Full Text] [Related]

  • 33. Paget's disease of bone: benefits of neridonate as a first treatment and in cases of relapse after clodronate.
    Filipponi P, Cristallini S, Policani G, Casciari C, Gregorio F.
    Bone; 1998 Dec; 23(6):543-8. PubMed ID: 9855463
    [Abstract] [Full Text] [Related]

  • 34. Improved treatment of Paget's disease with dimethylaminohydroxypropylidene bisphosphonate.
    Schweitzer DH, Zwinderman AH, Vermeij P, Bijvoet OL, Papapoulos SE.
    J Bone Miner Res; 1993 Feb; 8(2):175-82. PubMed ID: 8442435
    [Abstract] [Full Text] [Related]

  • 35. Intravenous aminopropylidene bisphosphonate in the treatment of severe polyostotic Paget's disease of bone.
    Fritz P, Lioté F, Kuntz D.
    Semin Arthritis Rheum; 1994 Feb; 23(4):282. PubMed ID: 8009260
    [No Abstract] [Full Text] [Related]

  • 36. Aminohexane diphosphonate in the treatment of Paget's disease of bone.
    Atkins RM, Yates AJ, Gray RE, Urwin GH, Hamdy NA, Beneton MN, Rosini S, Kanis JA.
    J Bone Miner Res; 1987 Aug; 2(4):273-9. PubMed ID: 3455614
    [Abstract] [Full Text] [Related]

  • 37. Changes in serum HDL and LDL cholesterol in patients with Paget's bone disease treated with pamidronate.
    Montagnani A, Gonnelli S, Cepollaro C, Campagna MS, Franci MB, Pacini S, Gennari C.
    Bone; 2003 Jan; 32(1):15-9. PubMed ID: 12584031
    [Abstract] [Full Text] [Related]

  • 38. Symptomatic and scintigraphic improvement after intravenous pamidronate treatment of Paget's disease of bone in patients with normal serum alkaline phosphatase levels.
    Ang G, Feiglin D, Moses AM.
    Endocr Pract; 2003 Jan; 9(4):280-3. PubMed ID: 14561571
    [Abstract] [Full Text] [Related]

  • 39. Diphosphonate treatment of Paget's disease.
    Finerman GA, Gonick HC, Smith RK, Mayfield JM.
    Clin Orthop Relat Res; 1976 Oct; (120):115-24. PubMed ID: 975646
    [Abstract] [Full Text] [Related]

  • 40. Preliminary study of multiple increasing oral doses of dimethyl-APD on bone metabolism dynamics and safety profile.
    Vega E, Mautalen C, Roldán EJ, Pérez Lloret A.
    Drugs Exp Clin Res; 1994 Oct; 20(3):103-8. PubMed ID: 7956716
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.